BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for KNOA PHARMA, FORMERLY REPORTED AS, PURDUE PHARMA L.P. · law firm

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

Monitoring legislative and regulatory activities impacting the pharmaceutical industry public health initiatives related to opioid antagonist therapy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.